Tokyo - Delayed Quote JPY

Sysmex Corporation (6869.T)

1,941.50 +12.50 (+0.65%)

At close: October 30 at 3:30:00 PM GMT+9

Sysmex (TSE:6869) Stock May Be A Bargain On Cash Flow

Simply Wall St. 22d ago

6869.T
+0.65%
6869.TW
Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players

GlobeNewswire 1mo ago

QDEL

6869.T
+0.65%
TRIB
VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in the Human Space.

Zacks Small Cap Research 1mo ago

VNRX

6869.T
+0.65%
RVTY
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics

GlobeNewswire 8mo ago

6869.T
+0.65%
ABT

BDX
Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh

GlobeNewswire 5mo ago

DHR

6869.T
+0.65%
ABT
Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux

GlobeNewswire 6mo ago

ABT

DHR

BIO
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry

GlobeNewswire 1mo ago

CTKB

6869.T
+0.65%
Medicaroid wins Europe’s CE mark for Hinotori surgical robot

MedTech Dive 3mo ago

ISRG

7012.T

6869.T
+0.65%
Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

GlobeNewswire 4mo ago

ABT

ADPT

ILMN
Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

GlobeNewswire 4mo ago

TMO

ABT

A
VolitionRx Announces Collaboration with Sysmex

PR Newswire 4mo ago

6869.T
+0.65%
VNRX
Is It Time To Reassess Sysmex (TSE:6869) After A Prolonged Share Price Slump?

Simply Wall St. 7mo ago

6869.T
+0.65%

U.S. markets closed

Sysmex Corporation (6869.T)

Sysmex (TSE:6869) Stock May Be A Bargain On Cash Flow

Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players

VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in the Human Space.

Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics

Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh

Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux

Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry

Medicaroid wins Europe’s CE mark for Hinotori surgical robot

Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

VolitionRx Announces Collaboration with Sysmex

Is It Time To Reassess Sysmex (TSE:6869) After A Prolonged Share Price Slump?